Gurmander Kohli
Plastic and Reconstructive Surgery · Loma Linda, CANPI 1225066962
Payments from drug & device makers
Across 54 payments — averaging $22.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acelrx Pharmaceuticals, Inc.$204
- AbbVie$168
- Cardiovascular Systems Inc.$127
- Bristol Myers Squibb$117
- Inari Medical, Inc.$93
- Amgen$66
- plus $430 from 17 others
What the payments were for
- Food & beverage$1,205100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,205 in reported general payments places this provider in the 40th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Other plastic and reconstructive surgery in Loma Linda
- Subhas GuptaLoma Linda$205K
- Shankar LakshmanPasadena$3.5M
- Corey MaasSan Francisco$1.5M
- Anne WallaceSan Diego$896K
- David KulberLos Angeles$340K
- Mark SuskiThousand Oaks$294K
- Arian MowlaviLaguna Beach$250K
- Hisham SeifyNewport Beach$215K
- Gregory BunckeSan Francisco$212K
- Charles LeeSan Francisco$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.